Your trusted destination for CME, CPD & Medical Education across the Middle East.
National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)
Dr. McShane graduated cum laude from Loyola University Chicago with a bachelor of science in biology and earned her medical doctorate from Loyola University Chicago Stritch School of Medicine. Her fellowship in pulmonary and critical care medicine was at the University of Chicago where she remained as faculty after finishing her training. She received the Clinical Service Award for junior faculty by the University of Chicago department of medicine.
In 2020, Dr. McShane accepted an invitation to further focus on NTM lung disease at the University of Texas Health Science Center Tyler (UTHSCT), in Tyler, TX, a nationally renowned acid-fast bacilli laboratory and national referral center for patients with NTM lung disease. At the UTHSCT, Dr. McShane built the center’s first biorepository of sputum and blood samples from bronchiectasis patients with and without NTM lung disease. She served as principal investigator for over twenty clinical trials in bronchiectasis and NTM lung disease, and she received the award for Excellence in Clinical Research from the UTHSCT Department of Medicine.
Dr. McShane served as associate editor for CHEST and the Journal of Clinical Tuberculosis and Other Mycobacteria. In addition, Dr. McShane served as chair of the U.S. National Bronchiectasis Research Registry Consortium from 2023 to 2024.
In August 2025, Dr. McShane moved to the National Heart Lung and Blood Institute at the National Institutes of Health to study the role of genetics in bronchiectasis and NTM lung disease.
